Skip to content

Inspection Record

MicroBioPharm Japan Co., Ltd — FDA 483 Findings

US FDAInspected 2026-02-13Published 2026-11-05 3 findingsProcess validationCleaning validationEquipment and facility

Inspectors Tamil ArasuThe inspectors who signed the published document.Inspector lookup

View the regulator's official source The source document is always the basis for judgement.

Findings

1Process validation

Your process validations are inadequate.

2Cleaning validation

Your firm failed to establish adequate written procedures for cleaning and maintenance of equipment used in the manufacture, processing, or holding of drug substances, and failed to validate cleaning procedures to ensure that equipment is routinely cleaned to prevent contamination.

3Equipment and facility

Your firm failed to establish and follow appropriate written procedures for equipment qualification.

A record as of the US FDA document published on 2026-11-05. Check the agency's announcements for any later corrective action, and rely on the original text. Translation and classification are machine-made.

MicroBioPharm Japan Co., Ltd company profile — full historyAll US FDA findings US FDA documents, 2026 Go to Findings search
Linked from (backlinks)
Briefs that featured this document
Weekly Newsletter

Get new findings like these every Monday

Every Monday we email the week's new findings and actions from the FDA, EMA, Health Canada and MFDS. Each one links to its record on our site, where you'll find the regulator's original document. We'll also let you know when the site gains new features. Unsubscribe any time with one click.

See recent findings first

Sent every Monday · a confirmation email follows when you subscribe · unsubscribe from the footer of any email.